When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like. This episode originally aired on November 8, 2022.
To learn more about how CNN protects listener privacy, visit cnn.com/privacy
Learn more about your ad choices. Visit podcastchoices.com/adchoices
The Benefits of Gratitude
How Worried Should You Be About Ultraprocessed Foods?
What You Need to Know About Bird Flu
What Camels Teach Us about the Future
The Joy of Food
Body Neutrality with Jameela Jamil
Do Diets Really Work?
Do These Quick Weight Loss Hacks Work?
Lindy West on what we’re getting wrong about weight
Is Obesity Really a Disease?
The Truth About Menopause and Weight Gain
Paging Dr. Gupta: What You Need to Know about the Alabama IVF Ruling
What You Need to know about Kids and High Body Weight
WeightWatchers CEO Explains Why ‘We Got It Wrong’
The Big Business Behind Weight Loss Drugs
Is Ozempic Really A Miracle Drug?
Why Our Bodies Fight Us on Losing Weight
What Weight Tells Us about Our Health
Chasing Life presents All There Is With Anderson Cooper
Making Resolutions with Chasing Life
Create your
podcast in
minutes
It is Free
Newscast
Consider This from NPR
What’s That Rash?
The Coronavirus Podcast
Coronavirus Central